{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:15:42Z","timestamp":1791281742427,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HD082554"],"award-info":[{"award-number":["R01 HD082554"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jacl.2021.09.051","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T08:59:46Z","timestamp":1633337986000},"page":"840-844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lipoprotein subtypes after testosterone therapy in transmasculine adolescents"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5222-5787","authenticated-orcid":false,"given":"Kate","family":"Millington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0554-8502","authenticated-orcid":false,"given":"Yee-Ming","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacl.2021.09.051_bib0001","article-title":"Heart Disease and Stroke Statistics\u20142012 Update","volume":"125","author":"Roger","year":"2011","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jacl.2021.09.051_bib0002","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1373\/clinchem.2004.032763","article-title":"Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: The Framingham study","volume":"50","author":"Freedman","year":"2004","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.jacl.2021.09.051_bib0003","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1210\/jc.2010-2061","article-title":"Sex differences in lipid and lipoprotein metabolism: It's not just about sex hormones","volume":"96","author":"Wang","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.jacl.2021.09.051_bib0004","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2009-0345","article-title":"Endocrine treatment of transsexual persons: An endocrine society clinical practice guideline","volume":"94","author":"Hembree","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jacl.2021.09.051_bib0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7","volume":"13","author":"Coleman","year":"2012","journal-title":"Int J Transgenderism"},{"issue":"4","key":"10.1016\/j.jacl.2021.09.051_bib0006","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein Particle Analysis by Nuclear Magnetic Resonance Spectroscopy","volume":"26","author":"Jeyarajah","year":"2006","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.jacl.2021.09.051_bib0007","first-page":"E1","article-title":"Association of Lipid, Inflammatory, and Metabolic Biomarkers with Age at Onset for Incident Coronary Heart Disease in Women","author":"Dugani","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"17","key":"10.1016\/j.jacl.2021.09.051_bib0008","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1161\/CIRCULATIONAHA.108.819359","article-title":"Are advanced lipoprotein testing and subfractionation clinically useful","volume":"119","author":"Mora","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2021.09.051_bib0009","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.yfrne.2017.04.001","article-title":"Sex differences in cardiovascular disease \u2013 Impact on care and outcomes","volume":"46","author":"Humphries","year":"2017","journal-title":"Front Neuroendocrinol"},{"issue":"5","key":"10.1016\/j.jacl.2021.09.051_bib0010","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archinte.165.5.510","article-title":"Hormone therapy, lipoprotein subclasses, and coronary calcification: The healthy women study","volume":"165","author":"Mackey","year":"2005","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.jacl.2021.09.051_bib0011","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2217\/clp.15.10","article-title":"An update on testosterone, HDL and cardiovascular risk in men","volume":"10","author":"Thirumalai","year":"2015","journal-title":"Clin Lipidol"},{"issue":"6","key":"10.1016\/j.jacl.2021.09.051_bib0012","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.metabol.2008.01.019","article-title":"The association of endogenous sex hormones with lipoprotein subfraction profile in the Multi-Ethnic Study of Atherosclerosis","volume":"57","author":"Vaidya","year":"2008","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.jacl.2021.09.051_bib0013","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41591-020-0751-5","article-title":"Using human genetics to understand the disease impacts of testosterone in men and women","volume":"26","author":"Ruth","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jacl.2021.09.051_bib0014","first-page":"E1","article-title":"Association of High-Density Lipoprotein Cholesterol with Sex Steroid Treatment in Transgender and Gender-Diverse Youth","author":"Millington","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"5","key":"10.1016\/j.jacl.2021.09.051_bib0015","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3173","article-title":"Cross-Sex Hormones and Metabolic Parameters in Adolescents With Gender Dysphoria","volume":"139","author":"Jarin","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.jacl.2021.09.051_bib0016","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13293-016-0067-9","article-title":"Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis","volume":"7","author":"Tack","year":"2016","journal-title":"Biol Sex Differ"},{"issue":"11","key":"10.1016\/j.jacl.2021.09.051_bib0017","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1210\/jc.2017-01643","article-title":"Sex Steroids and Cardiovascular Outcomes in Transgender Individuals: A Systematic Review and Meta-Analysis","volume":"102","author":"Maraka","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jacl.2021.09.051_bib0018","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/clinem\/dgz029","article-title":"Body Composition and Markers of Cardiometabolic Health in Transgender Youth Compared With Cisgender Youth","volume":"105","author":"Nokoff","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jacl.2021.09.051_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11154-018-9454-3","article-title":"Cardiovascular health in transgender people","volume":"19","author":"Irwig","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jacl.2021.09.051_bib0020","doi-asserted-by":"crossref","unstructured":"Valentine A, Nokoff NJ, Bonny A, et\u00a0al. Cardiometabolic Parameters Among Transgender Adolescent Males on Testosterone Therapy and Body Mass Index-Matched Cisgender Females. Transgender Heal. 2021;00(00):1-5. doi:10.1089\/trgh.2020.0052","DOI":"10.1089\/trgh.2020.0052"},{"issue":"4","key":"10.1016\/j.jacl.2021.09.051_bib0021","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-3742","article-title":"Hormonal Treatment in Young People With Gender Dysphoria: A Systematic Review","volume":"141","author":"Chew","year":"2018","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.jacl.2021.09.051_bib0022","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: A cohort study","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.jacl.2021.09.051_bib0023","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.118.038584","article-title":"Occurrence of Acute Cardiovascular Events in Transgender Individuals Receiving Hormone Therapy","volume":"139","author":"Nota","year":"2019","journal-title":"Circulation"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287421002506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287421002506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:36:19Z","timestamp":1761831379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287421002506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1933287421002506"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2021.09.051","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein subtypes after testosterone therapy in transmasculine adolescents","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2021.09.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}